Collagen Stimulator Nodules (Sculptra/Ellansé)

Small subclinical micronodules may soften over 6-12 months with diligent massage. However, visible or palpable nodules—especially those that have developed a fibrous capsule—rarely resolve spontaneously. Clinical evidence shows that mature nodules persist indefinitely without physical intervention. Early detection with ultrasound allows simpler treatment before the capsule fully matures.

Ellanse (polycaprolactone microspheres in carboxymethylcellulose gel) tends to form denser, more cohesive nodules than Sculptra (poly-L-lactic acid). Both require physical extraction, but Ellanse nodules typically need more mechanical fragmentation due to their material properties. The success rate is similar for both products when treated with our ultrasound-guided technique.

Traditional open surgery is rarely necessary. Our pinhole micro-extraction technique avoids large incisions in over 95% of cases. The entry point is needle-sized, leaving no visible scar. Only very large or deeply embedded nodules adherent to critical structures may require a small incision approach.

Once a nodule is physically extracted, that specific lesion does not recur. However, if residual product remains elsewhere in the treatment zone, new nodules can potentially form at those sites. This is why we perform comprehensive ultrasound scanning of the entire treatment area—not just the symptomatic spot—to identify and address all deposits in a single session.

Our technique preserves surrounding healthy fat and tissue. Minor contour irregularity is possible for larger nodules, but this is typically much less noticeable than the nodule itself. If significant volume loss occurs, it can be addressed with fat grafting or safe fillers after complete healing.

Nodules typically appear 3-12 months after injection, coinciding with the peak of the body's foreign body response. However, some cases present 1-2 years later, particularly when triggered by immune activation events. Regular ultrasound monitoring in the first year after biostimulator injection enables early detection and simpler treatment.

Steroids suppress the inflammatory component of the nodule—reducing swelling and tenderness—but they cannot dissolve the synthetic polymer particles that triggered the reaction. Once the steroid effect wears off, the immune system re-engages with the foreign body, and the nodule returns. Repeated steroid use also risks fat atrophy, creating visible depressions that can be worse than the original nodule.

Unfortunately, yes. This rebound pattern is common. Steroids suppress the inflammatory component temporarily, but the foreign body (PLLA particles) remains. When the steroid effect wears off, the immune system re-engages — often more aggressively than before. Each cycle also adds more fibrosis, making the nodule progressively harder. This is why we advocate for extraction rather than repeated steroid suppression.

Ellansé's carrier gel (carboxymethylcellulose) does absorb over months, but the polycaprolactone microspheres and the collagen they've stimulated do not simply disappear. If you have a palpable nodule, waiting typically means the body continues to build fibrous tissue around the particles, making the nodule harder and potentially larger. Early intervention produces better outcomes with less tissue disruption.

This is exactly why revision-only practices like FILLER REVISION exist. Your injector specializes in placing products — they aren't trained or equipped for extraction. You need ultrasound imaging to see the nodule, micro-instruments to extract it, and a doctor who does this daily. It's a different specialty entirely.